Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Clinical Oncology|August 28, 2021
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701Tomono Kawase, Hiroshi Imamura, Masahiro Goto, et al.
Plos One|November 3, 2012
Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndromeTakafumi Kawanami, Toshioki Sawaki, Tomoyuki Sakai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2015
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialKazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, et al.
The Journal of Clinical Investigation|October 28, 2010
Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient miceFei Wang, Yasuo Okamoto, Isao Inoki, et al.
Anticancer Research|March 4, 2025
A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final ResultsJunji Kawada, Daisuke Sakai, Yutaka Kimura, et al.
Oncology Letters|June 12, 2025
Clinical and prognostic characteristics of metastatic colorectal cancer with minor <i>RAS</i> mutationsYoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, et al.
The New England Journal of Medicine|May 30, 2020
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric CancerKohei Shitara, Yung-Jue Bang, Satoru Iwasa, et al.
International Journal of Clinical Oncology|May 16, 2020
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)Masahito Kotaka, Shigeyoshi Iwamoto, Hironaga Satake, et al.
International Journal of Clinical Oncology|March 29, 2020
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)Takashi Ohta, Takeshi Kato, Hisato Kawakami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2025
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction CancerHisato Kawakami, Shigenori Kadowaki, Akitaka Makiyama, et al.
Pageof 19